Myeloid-Derived Suppressor Cells Modulate Immune Responses Independently of NADPH Oxidase in the Ovarian Tumor Microenvironment in Mice

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Godoy, Heidi E ^a   Khan, A Nazmul H ^a   Vethanayagam, R Robert ^a   Grimm, Melissa J ^a   Singel, Kelly L ^a   Kolomeyevskaya, Nonna ^a   Sexton, Kevin J ^a   Parameswaran, Anupama ^a   Abrams, Scott I ^a   Odunsi, Kunle ^a   Segal, Brahm H ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE MARROW CELL; CANCER GROWTH; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENOTYPE; GRANULOCYTE; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; OVARY CARCINOMA; OVERALL SURVIVAL; PROTEIN FUNCTION; SUPPRESSOR CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; EXUDATES AND TRANSUDATES; FEMALE; GRANULOCYTES; IMMUNITY; MICE; MICE, INBRED C57BL; MYELOID CELLS; NADPH OXIDASE; OVARIAN NEOPLASMS; PERITONEUM; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 84880848042     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069631     Document Type: Article

References (52)

1. Sinha P, Parker KH, Horn L, Ostrand-Rosenberg S, (2012) Tumor-induced myeloid-derived suppressor cell function is independent of IFN-gamma and IL-4Ralpha. Eur J Immunol 42: 2052-2059.
2. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI, (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 181: 5791-5802.
3. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V, (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268.
4. Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, et al. (2007) Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 13: 828-835.
5. Srivastava MK, Zhu L, Harris-White M, Kar U, Huang M, et al. (2012) Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS ONE 7: e40677.
6. Hanson EM, Clements VK, Sinha P, Ilkovitch D, Ostrand-Rosenberg S, (2009) Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J Immunol 183: 937-944.
7. Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, et al. (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181: 4666-4675.
8. Li H, Han Y, Guo Q, Zhang M, Cao X, (2009) Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 182: 240-249.
9. Fortin C, Huang X, Yang Y, (2012) NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells. J Immunol 189: 1843-1849.
10. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC, (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13: 721s-726s.
11. Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, et al. (2010) Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116: 5738-5747.
12. Serafini P, Mgebroff S, Noonan K, Borrello I, (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 68: 5439-5449.
13. Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, et al. (2010) Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 70: 99-108.
14. Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, et al. (2008) Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest 118: 3367-3377.
15. Winter WE 3rd, Maxwell GL, Tian C, Carlson JW, Ozols RF, et al. (2007) Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25: 3621-3627.
16. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, et al. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348: 203-213.
17. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, et al. (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102: 18538-18543.
18. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949.
19. Scarlett UK, Rutkowski MR, Rauwerdink AM, Fields J, Escovar-Fadul X, et al. (2012) Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med 209: 495-506.
20. Obermajer N, Muthuswamy R, Odunsi KO, Edwards R, Kalinski P, (2011) PGE2-Dependent CXCL12 Production and CXCR4 Expression Control the Accumulation of Human MDSCs in Ovarian Cancer Environment. Cancer Res.
21. Segal BH, Veys P, Malech H, Cowan MJ, (2011) Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant 17: S123-131.
22. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, et al. (2008) Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205: 2235-2249.
23. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, et al. (2009) Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 182: 5693-5701.
24. Lechner MG, Liebertz DJ, Epstein AL, (2010) Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 185: 2273-2284.
25. Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, et al. (2011) Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J Transl Med 9: 90.
26. Obermajer N, Muthuswamy R, Odunsi K, Edwards RP, Kalinski P, (2011) PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res 71: 7463-7470.
27. Eckhorn R, Gail AM, Bruns A, Gabriel A, Al-Shaikhli B, et al. (2004) Different types of signal coupling in the visual cortex related to neural mechanisms of associative processing and perception. IEEE Trans Neural Netw 15: 1039-1052.
28. Jackson SH, Gallin JI, Holland SM, (1995) The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182: 751-758.
29. Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, et al. (2000) Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21: 585-591.
30. Efimova O, Szankasi P, Kelley TW, (2011) Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS ONE 6: e16013.
31. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, et al. (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202-209.
32. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, et al. (2006) NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218.
33. Jancic C, Savina A, Wasmeier C, Tolmachova T, El-Benna J, et al. (2007) Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol 9: 367-378.
34. Mantegazza AR, Savina A, Vermeulen M, Perez L, Geffner J, et al. (2008) NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood.
35. Segal BH, Han W, Bushey JJ, Joo M, Bhatti Z, et al. (2010) NADPH oxidase limits innate immune responses in the lungs in mice. PLoS ONE 5: e9631.
36. Segal BH, Grimm MJ, Khan AN, Han W, Blackwell TS, (2012) Regulation of innate immunity by NADPH oxidase. Free Radic Biol Med.
37. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
38. Ushio-Fukai M, Urao N, (2009) Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. Antioxid Redox Signal 11: 2517-2533.
39. Ando T, Mimura K, Johansson CC, Hanson MG, Mougiakakos D, et al. (2008) Transduction with the antioxidant enzyme catalase protects human T cells against oxidative stress. J Immunol 181: 8382-8390.
40. Sinha P, Clements VK, Ostrand-Rosenberg S, (2005) Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J Immunol 174: 636-645.
41. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI, (2004) Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 172: 989-999.
42. Kusmartsev S, Gabrilovich DI, (2003) Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J Leukoc Biol 74: 186-196.
43. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC, (1997) Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 185: 207-218.
44. Chang YC, Segal BH, Holland SM, Miller GF, Kwon-Chung KJ, (1998) Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. J Clin Invest 101: 1843-1850.
45. Meyer C, Sevko A, Ramacher M, Bazhin AV, Falk CS, et al. (2011) Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A 108: 17111-17116.
46. Waight JD, Hu Q, Miller A, Liu S, Abrams SI, (2011) Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE 6: e27690.
47. Abrams SI, Waight JD, (2012) Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression. Oncoimmunology 1: 550-551.
48. Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S, (2010) Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells. J Leukoc Biol 88: 839-848.
49. Smith C, Chang MY, Parker KH, Beury DW, Duhadaway JB, et al. (2012) IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development. Cancer Discov 2: 722-735.
50. Segal BH, Sakamoto N, Patel M, Maemura K, Klein AS, et al. (2000) Xanthine oxidase contributes to host defense against Burkholderia cepacia in the p47(phox-/-) mouse model of chronic granulomatous disease. Infect Immun 68: 2374-2378.
51. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, et al. (2011) TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472: 476-480.
52. Kubo H, Morgenstern D, Quinian WM, Ward PA, Dinauer MC, et al. (1996) Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase. J Clin Invest 97: 2680-2684.